Pancreatic Cancer Research

ResearcherZhongda Hospital Southeast UniversityActive in the last 2 years

Xilong Ou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7336-3764; OpenAlex author ID A5015337543. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. PPM1G promotes autophagy and progression of pancreatic cancer via upregulating HMGB1. Co-author DOI 10.1016/j.cellsig.2024.111342↗
  2. The global research and emerging trends in autophagy of pancreatic cancer: A bibliometric and visualized study. Last author DOI 10.3389/fonc.2022.987026↗
  3. MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. Co-author DOI 10.1186/s12935-016-0331-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qin Lu · 2 shared papers, 2022–2024 · strength 0.38
  2. Mingyang Song · 2 shared papers, 2022–2024 · strength 0.38
  3. Cheng Hang · 1 shared paper, 2016 · strength 0.06
  4. Hao Wang · 1 shared paper, 2016 · strength 0.06
  5. Jianxin Zhu · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.